03-05-2016 NMMDA: Direct communication to Healthcare Professionals regarding medicines containing fusafungine
13-04-2016 EMA: CHMP meeting highlights
31-03-2016 EMA: Recommendations to minimize ketoacidosis risk with SGLT2 inhibitors for diabetes, confirmed
02-02-2016 NICE: New technology appraisal on different treatments for people with severe rheumatoid arthritis
25-01-2016 Scientific Committee on Consumer Safety (SCCS) issues new revision of "Notes of Guidance"
20-01-2016 EGA adopts disclosure requirements for the generic, biosimilar and value added medicines industry
